News | February 17, 2023
Biocon Q3 FY23 revenue up 36%
The company's consolidated revenues for the quarter grew 36% to Rs. 3,020 crore on the back of robust performance across all its three businesses
The company's consolidated revenues for the quarter grew 36% to Rs. 3,020 crore on the back of robust performance across all its three businesses
He has global experience in strategic and operational leadership including at Board, CEO and Senior Corporate levels
The Innopack confex is a perfect platform for exhibitors to demonstrate their latest developments in the fields of pharmaceutical packaging, labelling, drug delivery device design and engineering.
Biocon has reported consolidated financial results for the period ended December 31, 2021
ICICI Direct gives a preview on the earnings narrative for Q3FY22
He has over 22 years of experience in pharmaceutical sales & business development
ICICI Direct gives an update on the 12 companies that it has covered in the healthcare universe. A report
An amount of Rs. 70.9 crore has been earmarked for funding capital expenditure for the proposed expansion
Number of approved manufacturing sites of Remdesivir in the country has increased from 22 sites to 60
Subscribe To Our Newsletter & Stay Updated
